175 related articles for article (PubMed ID: 37934354)
21. Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers.
Chen ZD; Chen Q; Zhu YT; Zhang YF; Zhan Y; Chen XF; Liang X; Jia JY; Yu C; Liu HY; Zou JJ; Liu YM; Zhong DF
Clin Ther; 2021 Sep; 43(9):e264-e273. PubMed ID: 34366153
[TBL] [Abstract][Full Text] [Related]
22. Bioequivalence study of domperidone dry suspension in healthy Chinese subjects under fasted and fed conditions: An open-label, randomized, single-dose, crossover trial.
Wu L; Huang Q; Lin M; Kai J; Huang Y; Zhai Y; Liu J; Shentu J
Int J Clin Pharmacol Ther; 2023 Jul; 61(7):320-328. PubMed ID: 36999513
[TBL] [Abstract][Full Text] [Related]
23. The effect of food and acid-reducing agents on the pharmacokinetic profile of capivasertib: Results from a randomized, crossover study.
Miller C; Sommavilla R; Murphy D; Morris T; Khatun M; Cullberg M
Br J Clin Pharmacol; 2023 Nov; 89(11):3330-3339. PubMed ID: 37328269
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
[TBL] [Abstract][Full Text] [Related]
25. Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.
Fitoussi S; Thang C; Lesauvage E; Barré J; Charron B; Filali-Ansary A; Lameyre V
Arzneimittelforschung; 2009; 59(7):370-6. PubMed ID: 19728565
[TBL] [Abstract][Full Text] [Related]
26. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
[TBL] [Abstract][Full Text] [Related]
27. Effects of food on the pharmacokinetics of ponatinib in healthy subjects.
Narasimhan NI; Dorer DJ; Niland K; Haluska F; Sonnichsen D
J Clin Pharm Ther; 2013 Dec; 38(6):440-4. PubMed ID: 23888935
[TBL] [Abstract][Full Text] [Related]
28. Effects of diet and gender on the pharmacokinetics of oral lenvatinib: A clinical trial in healthy Chinese participants.
Wei Y; Yu Y; Zhang W; Mu H; He K; Wen Q; Zhang X
Int J Clin Pharmacol Ther; 2023 Nov; 61(11):475-481. PubMed ID: 37644876
[TBL] [Abstract][Full Text] [Related]
29. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial.
Yang L; Zhang L; Luo Z
Drug Des Devel Ther; 2023; 17():2369-2381. PubMed ID: 37600497
[TBL] [Abstract][Full Text] [Related]
30. Impact of food and the proton pump inhibitor rabeprazole on the pharmacokinetics of GDC-0941 in healthy volunteers: bench to bedside investigation of pH-dependent solubility.
Ware JA; Dalziel G; Jin JY; Pellett JD; Smelick GS; West DA; Salphati L; Ding X; Sutton R; Fridyland J; Dresser MJ; Morrisson G; Holden SN
Mol Pharm; 2013 Nov; 10(11):4074-81. PubMed ID: 24099279
[TBL] [Abstract][Full Text] [Related]
31. Effect of food on the pharmacokinetics and pharmacodynamics of R1663, an oral factor Xa inhibitor, in healthy male volunteers.
Schmitt C; Charoin-Pannier A; McIntyre C; Zandt H; Ciorciaro C; Zweigler L; Winters K; Pepper T
Int J Clin Pharmacol Ther; 2012 Aug; 50(8):566-72. PubMed ID: 22735461
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
33. Effects of a High-fat Meal on the Pharmacokinetics of the VEGFR Inhibitor Fruquintinib: A Randomized Phase I Study in Healthy Subjects.
Qian H; Fan S; Li K; Sai Y; Su W; Chen Q; Liu Y; Li T; Wang W; Jia J; Yu C; Liu Y
Clin Ther; 2019 Aug; 41(8):1537-1544. PubMed ID: 31272709
[TBL] [Abstract][Full Text] [Related]
34. Effect of a high-fat and high-calorie food on the pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy subjects.
Wu Q; Zhu H; Song R; Zhang M; Li F; Zeng W; Wang W; Jia J; Yu C; Liu Y
Pharmacol Res Perspect; 2023 Jun; 11(3):e01102. PubMed ID: 37208866
[TBL] [Abstract][Full Text] [Related]
35. Unveiling the Influence of a High-Fat Meal on the Pharmacokinetics of Oral Globalagliatin, A Glucokinase Activator, in Healthy Chinese Volunteers.
Xu M; Wang Y; Wang X; Pu Z; Liu Y; Jiang C; Shen X; Sun H; Xie H
Drugs R D; 2024 Mar; 24(1):41-50. PubMed ID: 37985605
[TBL] [Abstract][Full Text] [Related]
36. Phase I crossover study of DNA-protein kinase inhibitor peposertib in healthy volunteers: Effect of food and pharmacokinetics of an oral suspension.
Becker A; Krebs-Brown A; Vetter C; Reuter T; Rodriguez-Gutierrez A; You X; Lissy M
Clin Transl Sci; 2023 Dec; 16(12):2628-2639. PubMed ID: 37905356
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.
Li Y; Jiang X; Lan K; Zhang R; Li X; Jiang Q
Clin Ther; 2007 Oct; 29(10):2194-203. PubMed ID: 18042475
[TBL] [Abstract][Full Text] [Related]
38. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
[TBL] [Abstract][Full Text] [Related]
39. An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions.
Joshi S; Gudi G; Menon VCA; Tandon M; Joshi V; Suryawanshi S; Barkate H; Sawant N; Katare S; Siddique W
Clin Pharmacokinet; 2020 Mar; 59(3):349-357. PubMed ID: 31583610
[TBL] [Abstract][Full Text] [Related]
40. SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors.
Xia ZJ; Ji YC; Sun DQ; Peng X; Gao YL; Fang YF; Zhao XD; Wang WB; Ding J; Geng MY; Ai J
Acta Pharmacol Sin; 2021 Jun; 42(6):998-1004. PubMed ID: 32918045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
